Integral Health Asset Management, LLC Aclaris Therapeutics, Inc. Transaction History

Integral Health Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$7.07 - $17.95 $1.03 Million - $2.6 Million	-145,000 Reduced 39.19%	225,000 $1.82 Million
Q4 2022 Feb 13, 2023	BUY	$14.33 - $18.37 $429,900 - $551,100	30,000 Added 8.82%	370,000 $5.83 Million
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $706,159 - $984,408	54,029 Added 18.89%	340,000 $5.35 Million
Q2 2022 Aug 03, 2022	BUY	$10.16 - $17.08 $487,385 - $819,344	47,971 Added 20.16%	285,971 $3.99 Million
Q1 2022 May 12, 2022	BUY	$9.74 - $17.92 $370,120 - $680,960	38,000 Added 19.0%	238,000 $4.1 Million
Q4 2021 Feb 02, 2022	BUY	$12.27 - $18.49 $184,050 - $277,350	15,000 Added 8.11%	200,000 $2.91 Million
Q3 2021 Nov 12, 2021	BUY	$13.38 - $18.8 $133,800 - $188,000	10,000 Added 5.71%	185,000 $3.33 Million
Q2 2021 Aug 30, 2021	SELL	$17.08 - $29.6 $2.99 Million - $5.18 Million	-175,000 Reduced 50.0%	175,000 $3.07 Million
Q2 2021 Aug 13, 2021	BUY	$17.08 - $29.6 $5.98 Million - $10.4 Million	350,000 New	350,000 $6.15 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $253M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.